FI852205L - 7-(3-aryl-1-piperazinyl)- samt 7-(3-cyklohexyl-1-piperazinyl)-3-kinolonkarboxylsyror. - Google Patents

7-(3-aryl-1-piperazinyl)- samt 7-(3-cyklohexyl-1-piperazinyl)-3-kinolonkarboxylsyror.

Info

Publication number
FI852205L
FI852205L FI852205A FI852205A FI852205L FI 852205 L FI852205 L FI 852205L FI 852205 A FI852205 A FI 852205A FI 852205 A FI852205 A FI 852205A FI 852205 L FI852205 L FI 852205L
Authority
FI
Finland
Prior art keywords
carbon atoms
piperazinyl
cyclohexyl
phenacyl
dimethylamino
Prior art date
Application number
FI852205A
Other languages
English (en)
Other versions
FI82041B (fi
FI852205A0 (fi
FI82041C (fi
Inventor
Uwe Petersen
Klaus Grohe
Hans-Joachim Zeiler
Karl Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI852205A0 publication Critical patent/FI852205A0/fi
Publication of FI852205L publication Critical patent/FI852205L/fi
Publication of FI82041B publication Critical patent/FI82041B/fi
Application granted granted Critical
Publication of FI82041C publication Critical patent/FI82041C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI852205A 1984-06-04 1985-05-31 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-cyklopropyl-6-fluor-1,4-dihydro-4-pxo-7- (1-piperazinyl)-3-kinolinkarboxylsyraderivat. FI82041C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843420798 DE3420798A1 (de) 1984-06-04 1984-06-04 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
DE3420798 1984-06-04

Publications (4)

Publication Number Publication Date
FI852205A0 FI852205A0 (fi) 1985-05-31
FI852205L true FI852205L (fi) 1985-12-05
FI82041B FI82041B (fi) 1990-09-28
FI82041C FI82041C (fi) 1991-01-10

Family

ID=6237597

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852205A FI82041C (fi) 1984-06-04 1985-05-31 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-cyklopropyl-6-fluor-1,4-dihydro-4-pxo-7- (1-piperazinyl)-3-kinolinkarboxylsyraderivat.

Country Status (21)

Country Link
US (1) US4599334A (fi)
EP (1) EP0169993B1 (fi)
JP (2) JPS611683A (fi)
KR (1) KR920000759B1 (fi)
AT (1) ATE39488T1 (fi)
AU (1) AU571333B2 (fi)
CA (1) CA1248954A (fi)
DD (1) DD240016A5 (fi)
DE (2) DE3420798A1 (fi)
DK (1) DK162527C (fi)
ES (3) ES8607294A1 (fi)
FI (1) FI82041C (fi)
GR (1) GR851314B (fi)
HU (1) HU194866B (fi)
IE (1) IE57814B1 (fi)
IL (1) IL75370A (fi)
NO (1) NO165105C (fi)
NZ (1) NZ212271A (fi)
PH (1) PH22492A (fi)
PT (1) PT80580B (fi)
ZA (1) ZA854168B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US5468861A (en) * 1984-06-04 1995-11-21 Bayer Aktiengesellschaft 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and alkyl esters thereof
JPS6259263A (ja) * 1985-09-10 1987-03-14 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPH0637489B2 (ja) * 1985-09-21 1994-05-18 杏林製薬株式会社 キノロンカルボン酸誘導体およびその製造方法
HU196411B (en) * 1985-09-24 1988-11-28 Hoffmann La Roche Process for producing quinoline derivatives and pharmaceutical compositions containing them
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
EP0230053A3 (en) * 1986-01-17 1988-03-30 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
HU204512B (en) * 1986-01-20 1992-01-28 Kyorin Seiyaku Kk New process for producing quinoline-carboxylic acid derivatives
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
US4689423A (en) * 1986-04-01 1987-08-25 Warner-Lambert Company Process for the preparation of 2,3,4,5-tetrafluorobenzoyl acetates
HU196987B (en) * 1986-10-15 1989-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing quinoline-carboxylic acid derivatives
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
NZ229605A (en) * 1988-07-15 1990-07-26 Abbott Lab Preparation of 1,4-dihydro-6-fluoro-7-(piperazin-1-yl)-4-oxo-3-quinoline (or naphthyridine) carboxylic acid derivatives
FR2664595B1 (fr) * 1990-07-10 1992-09-18 Bellon Labor Sa Roger Nouveaux derives de benzonaphtyridine-1,8, leur preparation et les compositions qui les contiennent.
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
FR2653663A1 (en) * 1989-10-30 1991-05-03 Bellon Labor Sa Roger Novel benzo[1,8]naphthyridine derivatives, their preparation and compositions containing them
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
ATE193890T1 (de) 1990-04-18 2000-06-15 Procter & Gamble Pharma Antimikrobielle chinolonyl-lactame
DE10108750A1 (de) * 2001-02-23 2002-09-05 Bayer Ag Verbessertes Verfahren zur Herstellung von Fluorchinoloncarbonsäuren
KR100519158B1 (ko) * 2002-12-21 2005-10-06 주식회사유한양행 퀴놀론 카르복실레이트 유도체의 제조방법
SMP200800058B (it) * 2006-03-28 2009-09-07 Procter & Gamble Sali e polimorfi malati di un acido (3s, 5s) -7- [3-ammino-5-metilpiperidinil]-1-ciclopropil-1,4-diidro-8-metossi-4-osso-3-chinolincarbossilico
US7456279B2 (en) * 2006-03-28 2008-11-25 The Procter & Gamble Company Coupling process for preparing quinolone intermediates
DK3784656T3 (da) 2018-04-25 2023-09-18 Elanco Animal Health Gmbh Fremgangsmåde til hydrolyse af quinoloncarboxylestere

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
DE3142856A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-dichlor-5-fluor-benzoylchlorid
JPS5910580A (ja) * 1982-07-09 1984-01-20 Hokuriku Seiyaku Co Ltd 7−フエニル置換ピペラジノ−4−オキソ−1,4−ジヒドロキノリン−3−カルボン酸誘導体
JPS5929685A (ja) * 1982-08-11 1984-02-16 Hokuriku Seiyaku Co Ltd 7−置換フエニルピペラジノ−4−オキソ−1,4−ジヒドロキノリン−3−カルボン酸誘導体
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306772A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Also Published As

Publication number Publication date
GR851314B (fi) 1985-11-25
HUT39175A (en) 1986-08-28
ES8607294A1 (es) 1986-06-01
EP0169993A2 (de) 1986-02-05
ES552573A0 (es) 1987-11-01
DK249685A (da) 1985-12-05
FI82041B (fi) 1990-09-28
DE3420798A1 (de) 1985-12-05
NO852063L (no) 1985-12-05
DK162527B (da) 1991-11-11
JPH06279411A (ja) 1994-10-04
ES8800196A1 (es) 1987-11-01
DD240016A5 (de) 1986-10-15
ES552574A0 (es) 1987-11-01
KR860000280A (ko) 1986-01-27
AU4320685A (en) 1985-12-12
AU571333B2 (en) 1988-04-14
NO165105C (no) 1990-12-27
IE851364L (en) 1985-12-04
EP0169993A3 (en) 1986-03-26
IL75370A (en) 1989-03-31
ES543839A0 (es) 1986-06-01
KR920000759B1 (ko) 1992-01-21
IL75370A0 (en) 1985-09-29
CA1259315C (fi) 1989-09-12
DK249685D0 (da) 1985-06-03
US4599334A (en) 1986-07-08
DK162527C (da) 1992-03-30
EP0169993B1 (de) 1988-12-28
ES8800195A1 (es) 1987-11-01
PH22492A (en) 1988-09-12
NO165105B (no) 1990-09-17
ATE39488T1 (de) 1989-01-15
FI852205A0 (fi) 1985-05-31
FI82041C (fi) 1991-01-10
JPS611683A (ja) 1986-01-07
IE57814B1 (en) 1993-04-21
CA1248954A (en) 1989-01-17
PT80580A (en) 1985-07-01
HU194866B (en) 1988-03-28
ZA854168B (en) 1986-01-29
DE3567021D1 (en) 1989-02-02
PT80580B (pt) 1987-11-11
NZ212271A (en) 1988-10-28

Similar Documents

Publication Publication Date Title
FI852205A0 (fi) 7-(3-aryl-1-piperazinyl)- samt 7-(3-cyklohexyl-1-piperazinyl)-3-kinolonkarboxylsyror.
LU88361I2 (fr) Excenel
ES543837A0 (es) Acidos 1-ciclopropil-6-fluor-1,4-dihidro-4-oxo-7-(3-oxo-1- piperazinil)-3-quinolin-carboxilicos
ATE45738T1 (de) 1-cyclopropyl-1,4-dihydro-4-oxo-7-(4-(2-oxo-1,3 dioxol-4-yl-methyl)-1-piperazinyl>-3chinolincarbons|uren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel.
KR830004320A (ko) 퀴나졸린 유도체의 제조방법
DK320485D0 (da) Ether-oxid-derivater af cyclopropylphenoler, deres fremstilling oganvendelse
ZA841418B (en) N-arylpiperazine derivatives
DE3278074D1 (de) Imidazolecarboxylic acid derivatives
ZA8312B (en) Substituted 1-benzoyl-2-phenyliminiomidazolidine derivatives
GR79010B (fi)
FI882658A (fi) Mellanprodukter som aer anvaendbara vid framstaellning av som dopaminagonister anvaendbara pyrimido (4,5-g) kinoliner.
KR890006589A (ko) 7-아미노-1-사이클로프로필-8-클로로-6-플루오로-1,4-디하이드로-4-옥소-3-퀴놀린 카복실산, 이의 제조방법 및 이 화합물을 함유하는 항균제
FI922482A (fi) Foerfarande foer framstaellning av kinolinfoerening.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT